- Home
- CHRS vs HITI Comparison
CHRS vs HITI Comparison
Compare CHRS & HITI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRS
- HITI
- Stock Information
- Founded
- CHRS 2010
- HITI 2009
- Country
- CHRS United States
- HITI Canada
- Employees
- CHRS N/A
- HITI N/A
- Industry
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- HITI
- Sector
- CHRS Health Care
- HITI
- Exchange
- CHRS Nasdaq
- HITI Nasdaq
- Market Cap
- CHRS 84.2M
- HITI 187.8M
- IPO Year
- CHRS 2014
- HITI N/A
- Fundamental
- Price
- CHRS $0.82
- HITI $2.36
- Analyst Decision
- CHRS Buy
- HITI Strong Buy
- Analyst Count
- CHRS 3
- HITI 2
- Target Price
- CHRS $4.68
- HITI $4.75
- AVG Volume (30 Days)
- CHRS 1.3M
- HITI 283.5K
- Earning Date
- CHRS 08-07-2025
- HITI 06-16-2025
- Dividend Yield
- CHRS N/A
- HITI N/A
- EPS Growth
- CHRS N/A
- HITI N/A
- EPS
- CHRS N/A
- HITI N/A
- Revenue
- CHRS $272,251,000.00
- HITI $398,202,371.00
- Revenue This Year
- CHRS N/A
- HITI $12.43
- Revenue Next Year
- CHRS $106.56
- HITI $11.39
- P/E Ratio
- CHRS $1.90
- HITI N/A
- Revenue Growth
- CHRS 19.87
- HITI 9.22
- 52 Week Low
- CHRS $0.66
- HITI $1.57
- 52 Week High
- CHRS $2.43
- HITI $3.62
- Technical
- Relative Strength Index (RSI)
- CHRS 53.65
- HITI 54.32
- Support Level
- CHRS $0.72
- HITI $2.24
- Resistance Level
- CHRS $0.77
- HITI $2.35
- Average True Range (ATR)
- CHRS 0.04
- HITI 0.09
- MACD
- CHRS 0.01
- HITI 0.01
- Stochastic Oscillator
- CHRS 91.74
- HITI 86.27
About CHRS Coherus BioSciences Inc.
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.
About HITI High Tide Inc.
High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically integrated company in the Canadian cannabis market with various brands in its portfolio such as Canna Cabana, Fastendr, Queen of Bud, Grasscity, Daily High Club, Famous Brandz, and others. The company's reportable operating segments are; Bricks and mortar which generates maximum revenue, and E-commerce. Geographically, it derives maximum revenue from its business in Canada followed by the United States of America, and other international markets.